Literature DB >> 2208567

Chromosomal abnormalities in human breast cancer.

W M Mars1, G F Saunders.   

Abstract

This review emphasizes cytogenetic changes and DNA analyses by Southern blot in primary breast tumors, rather than metastases, established cell lines, and pleural effusions. The data suggests that the most frequently altered chromosomes and chromosome regions are 1p, 1q, 2q, 3p, 5, 6q, 8p, 8q, 11p, 11q, 12, 13q, 14q, 16, 17p, and 17q. Changes on 8q, 11p, 11q, 13q, and 17q appear to be associated with either progression of the disease or poor prognosis. Alterations on 1p and 3p may represent early events in the development of breast cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2208567     DOI: 10.1007/bf00047587

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  52 in total

1.  Proto-oncogene amplification and human breast tumor phenotype.

Authors:  J Adnane; P Gaudray; M P Simon; J Simony-Lafontaine; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

2.  Human breast carcinomas: marker chromosomes involving 1q in seven cases.

Authors:  Q V Cruciger; S Pathak; R Cailleau
Journal:  Cytogenet Cell Genet       Date:  1976

Review 3.  Genetic variability of proto-oncogenes for breast cancer risk and prognosis.

Authors:  R Lidereau; D Mathieu-Mahul; C Escot; C Theillet; M H Champeme; S Cole; M Mauchauffe; I Ali; J Amione; R Callahan
Journal:  Biochimie       Date:  1988-07       Impact factor: 4.079

4.  Transposition, amplification, and divergence in the origin of the DNF15 loci, a polymorphic repetitive sequence family on chromosomes 1 and 3.

Authors:  H M Welch; J K Darby; A J Pilz; C M Ko; B Carritt
Journal:  Genomics       Date:  1989-10       Impact factor: 5.736

5.  Rare HRAS alleles and susceptibility to human breast cancer.

Authors:  J M Hall; B Huey; J Morrow; B Newman; M Lee; E Jones; C Carter; G C Buehring; M C King
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

Review 6.  Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men.

Authors:  G Klein
Journal:  Cell       Date:  1983-02       Impact factor: 41.582

7.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

8.  Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/tetraploid range investigated using direct preparations.

Authors:  S M Hill; C S Rodgers; M A Hultén
Journal:  Cancer Genet Cytogenet       Date:  1987-01

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

Authors:  J Mackay; P A Elder; D J Porteous; C M Steel; R A Hawkins; J J Going; U Chetty
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more
  6 in total

1.  Relation between deletion of chromosome 1p36 and DNA ploidy in breast carcinoma: an interphase cytogenetic study.

Authors:  F Farabegoli; N Baldini; D Santini; C Ceccarelli; M Taffurelli; D Treré; M Derenzini
Journal:  Clin Mol Pathol       Date:  1996-04

2.  Expression of cell cycle proteins in male breast carcinoma.

Authors:  Rani Kanthan; Isabella Fried; Theresa Rueckl; Jenna-Lynn Senger; Selliah Chandra Kanthan
Journal:  World J Surg Oncol       Date:  2010-02-12       Impact factor: 2.754

3.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications.

Authors:  K Dhingra; A Sahin; J Supak; S Y Kim; G Hortobagyi; W N Hittelman
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Enhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells.

Authors:  B A Arrick; R L Grendell; L A Griffin
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

Review 6.  Gene therapy for carcinoma of the breast: Genetic ablation strategies.

Authors:  D T Curiel
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.